Drug metabolism and disposition in children

被引:100
作者
Benedetti, MS
Baltes, EL
机构
[1] UCB Pharma, F-92003 Nanterre, France
[2] UCB Pharma, B-1420 Braine lAlleud, Belgium
关键词
absorption in children; disposition in children; drug metabolizing enzymes; metabolism in children;
D O I
10.1046/j.1472-8206.2003.00140.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Key factors undergoing maturational changes accounting for differences in drug metabolism and disposition in the pediatric population compared with adults are reviewed. Gastric and duodenal pH, gastric emptying time, intestinal transit time, bacterial colonization and probably P-glycoprotein are important factors for drug absorption, whereas key factors explaining differences in drug distribution between the pediatric population and adults are membrane permeability, plasma protein concentration and plasma protein characteristics, endogenous substances in plasma, total body and extracellular water, fat content, regional blood flow and probably P-glycoprotein, mainly that present in the gut, liver and brain. As far as drug metabolism is concerned, important differences have been found in the pediatric population compared with adults both for phase I enzymes [oxidative (e.g. cytochrome CYP3A7 vs. CYP3A4 and CYP1A2), reductive and hydrolytic enzymes] and phase II enzymes (e.g. N-methyltransferases and glucuronosyltransferases). Finally, key factors undergoing maturational changes accounting for differences in renal excretion in the pediatric population compared with adults are glomerular filtration and tubular secretion. It would be important to generate information on the developmental aspects of renal P-glycoprotein and of other renal transporters as done and still being done with the different isozymes involved in drug metabolism.
引用
收藏
页码:281 / 299
页数:19
相关论文
共 185 条
[1]   The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians [J].
Akinyinka, OO ;
Sowunmi, A ;
Honeywell, R ;
Renwick, AG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (02) :159-165
[2]   AGE-RELATED DIFFERENCES IN SALICYLAMIDE AND ACETAMINOPHEN CONJUGATION IN MAN [J].
ALAM, SN ;
ROBERTS, RJ ;
FISCHER, LJ .
JOURNAL OF PEDIATRICS, 1977, 90 (01) :130-135
[3]   Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients [J].
Anderson, BJ ;
McKee, AD ;
Holford, NHG .
CLINICAL PHARMACOKINETICS, 1997, 33 (05) :313-327
[4]  
[Anonymous], DERMATOL THER, DOI DOI 10.1046/J.1529-8019.2000.00040.X
[5]   POSTNATAL-DEVELOPMENT OF RENAL-FUNCTION IN PRE-TERM AND FULL-TERM INFANTS [J].
APERIA, A ;
BROBERGER, O ;
ELINDER, G ;
HERIN, P ;
ZETTERSTROM, R .
ACTA PAEDIATRICA SCANDINAVICA, 1981, 70 (02) :183-187
[6]   PHARMACOKINETIC ASPECTS OF THEOPHYLLINE IN PREMATURE NEWBORNS [J].
ARANDA, JV ;
SITAR, DS ;
PARSONS, WD ;
LOUGHNAN, PM ;
NEIMS, AH .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (08) :413-416
[7]  
ARANDA JV, 1983, P 2 WORLD C CLIN PHA, P870
[8]  
BARNETT HL, 1949, PEDIATRICS, V3, P418
[9]   STEREOSELECTIVITY OF IDARUBICIN REDUCTION IN VARIOUS ANIMAL SPECIES AND HUMANS [J].
BENEDETTI, MS ;
PIANEZZOLA, E ;
FRAIER, D ;
CASTELLI, MG ;
DOSTERT, P .
XENOBIOTICA, 1991, 21 (04) :473-480
[10]  
Benedetti MS, 1995, PROG BRAIN RES, V106, P123